Functioning and work performance after long-term treatment with fremanezumab in migraine patients: a patient survey study following completion of a 1-year extension study

被引：0
|
作者：
Buse, Dawn C. [1 ]
Cloud, Blaine [2 ]
Gandhi, Sanjay K. [3 ]
Cohen, Joshua M. [3 ]
Ramirez-Campos, Verena [3 ]
Lipton, Richard B. [1 ]
机构：
[1] Albert Einstein Coll Med, Dept Neurol, New York, NY USA
[2] Clin SCORE, Chadds Ford, PA USA
[3] Teva Pharmaceut Ind, Frazer, PA USA
来源：
CEPHALALGIA | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC-PO-388
引用
收藏
页码：254 / 254
页数：1
相关论文
共 50 条
  • [1] Patient satisfaction with fremanezumab treatment in migraine: results from a patient survey after completion of a 1-year extension study
    Lipton, Richard B.
    Gandhi, Sanjay K.
    Cohen, Joshua M.
    Cloud, Blaine
    Ramirez-Campos, Verena
    Ahn, Andrew H.
    Buse, Dawn C.
    CEPHALALGIA, 2019, 39 : 253 - 253
  • [2] Patient preference for and satisfaction with fremanezumab following completion of a 1-year extension study
    Cowan, Robert P.
    Gandhi, Sanjay K.
    Cohen, Joshua M.
    Cloud, Blaine
    Buse, Dawn C.
    Ramirez-Campos, Verena
    Ahn, Andrew H.
    Lipton, Richard B.
    CEPHALALGIA, 2019, 39 : 264 - 265
  • [3] Patient Satisfaction with Fremanezumab Treatment for Chronic or Episodic Migraine: Results from a Web-Based, Patient Survey Following Completion of a 1-Year Extension Study
    Lipton, R. B.
    Gandhi, S. K.
    Cohen, J. M.
    Cloud, B.
    Ramirez-Campos, V
    Ahn, A. H.
    Buse, D.
    HEADACHE, 2019, 59 : 200 - 201
  • [4] Changes in anxiety, sleep, and need for rescue medications in migraine patients on fremanezumab therapy: patient survey results following completion of a 1-year extension study
    Buse, Dawn C.
    Gandhi, Sanjay K.
    Cohen, Joshua M.
    Cloud, Blaine
    Ramirez-Campos, Verena
    Lipton, Richard B.
    CEPHALALGIA, 2019, 39 : 241 - 241
  • [5] Patient Preference for Dosing Regimen and Perception of Dosing Flexibility With Fremanezumab for Migraine: Results From a Patient Survey Following Completion of a 1-Year Extension Study
    Cowan, Robert P.
    Gandhi, Sanjay K.
    Cloud, Blaine
    Cohen, Joshua M.
    Buse, Dawn C.
    Ramirez-Campos, Verena
    Ahn, Andrew H.
    Lipton, Richard B.
    NEUROLOGY, 2020, 94 (15)
  • [6] Patient preference for dosing regimen and perception of dosing flexibility with fremanezumab for migraine: results from a patient survey following completion of a 1-year extension study
    Cowan, Robert P.
    Gandhi, Sanjay K.
    Cloud, Blaine
    Cohen, Joshua M.
    Buse, Dawn C.
    Ramirez-Campos, Verena
    Ahn, Andrew H.
    Lipton, Richard B.
    CEPHALALGIA, 2019, 39 : 263 - 264
  • [7] Long-Term Efficacy and Safety of Fremanezumab in Migraine: Results of a 1-Year Study
    Goadsby, P. J.
    Monteith, T.
    Cohen, J. M.
    Yang, R.
    HEADACHE, 2019, 59 : 99 - 99
  • [8] Long-Term Efficacy and Safety of Fremanezumab in Migraine: Results of a 1-Year Study
    Goadsby, Peter
    Monteith, Teshamae
    Yeung, Paul P.
    Cohen, Joshua
    Yang, Ronghua
    NEUROLOGY, 2019, 92 (15)
  • [9] Long-Term Safety of Fremanezumab: Results of a 1-Year Study
    Ning, Xiaoping
    Cohen, Joshua
    Bennett, Nathan
    Yeung, Paul
    Yang, Ronghua
    NEUROLOGY, 2019, 92 (15)
  • [10] Long-Term Safety of Fremanezumab: Results of a 1-Year Study
    Ning, X.
    Cohen, J. M.
    Bennett, N. L.
    Yang, R.
    HEADACHE, 2019, 59 : 47 - 47
12345